Related references
Note: Only part of the references are listed.HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme
N. J. Polman et al.
PREVENTIVE MEDICINE (2019)
Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program
Dorothy A. Machalek et al.
MEDICAL JOURNAL OF AUSTRALIA (2019)
Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial (vol 320, pg 43, 2018)
G. S. Ogilvie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records
Rebecca Landy et al.
PREVENTIVE MEDICINE (2018)
Screening for Cervical Cancer in Primary Care A Decision Analysis for the US Preventive Services Task Force
Jane J. Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
Maria Demarco et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2017)
Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results
Sandra D. Isidean et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy
Reem A. Mustafa et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2016)
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
Allan Hildesheim et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
A cohort study of cervical screening using partial HPV typing and cytology triage
Mark Schiffman et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Similar Risk Patterns After Cervical Screening in Two Large US Populations Implications for Clinical Guidelines
Julia C. Gage et al.
OBSTETRICS AND GYNECOLOGY (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2015)
Worldwide incidence of cervical lesions: a systematic review
J. Ting et al.
EPIDEMIOLOGY AND INFECTION (2015)
Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
Louise T. Thomsen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-PositiveWomen? APOBASCAMTrial Substudy
Maaike G. Dijkstra et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
Cosette M. Wheeler et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Five-Year Risks of CIN 3+and Cervical Cancer Among Women Who Test Pap-Negative But Are HPV-Positive
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
OBSTETRICS AND GYNECOLOGY (2013)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
Mark Schiffman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
Hui-Chi Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model
Ralph P. Insinga et al.
BMC INFECTIOUS DISEASES (2009)
Natural history of persistent high-risk human papillomavirus infections in Korean women
Jaeman Bae et al.
GYNECOLOGIC ONCOLOGY (2009)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
Modeling human papillomavirus vaccine effectiveness: Quantifying the impact of parameter uncertainty
Nicolas Van de Velde et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
Jack Cuzick et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Natural history of cervical intraepithelial neoplasia - A meta-analysis
SB Cantor et al.
ACTA CYTOLOGICA (2005)
Share Paper
